Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

Clinical trial NCT00058084 · COMPLETED

Trial details

NCT number: NCT00058084
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2003-03-01
Primary completion: 2007-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.